Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based Infant Formula
Prnewswire·2025-11-18 20:30

公司事件与政策影响 - 美国2026财年联邦预算案获得两院两党通过 正式结束了美国政府停摆 这对公司而言是一个重要的里程碑 [1] - 该预算协议为创新性、非大豆的植物基婴儿营养品在“鹳鸟行动速度”计划下加速通过FDA审批开辟了途径 [1] 公司业务与市场定位 - 公司是全球婴幼儿、学步儿童、儿童及成人全食物、植物基营养领域的先驱 [1] - 公司股票在多个交易所交易 代码分别为BABY、BABYF和0YL.F [1]

Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based Infant Formula - Reportify